• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550300-38
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dyspnea (1816); Hypoxia (1918); Myocardial Infarction (1969); Neurological Deficit/Dysfunction (1982); Tachycardia (2095); Stenosis (2263); Heart Failure/Congestive Heart Failure (4446)
Event Date 09/28/2020
Event Type  Injury  
Manufacturer Narrative
The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
Patient id: (b)(6).It was reported that the procedure was performed on (b)(6) 2019, to treat a target lesion in the heavily calcified mid left anterior descending (lad) artery.The 2.75 x 38 mm xience sierra stent was implanted, treating the target lesion.On (b)(6) 2020, the patient began to experience shortness of breath (sob) and presented to the emergency department with sob, tachycardia, hypoxia and altered mental status.The patient was placed on bilevel positive airway pressure (bipap), and the patient¿s condition improved with oxygenation.Electrocardiogram noted changes and troponin levels were elevated.In-stent restenosis of 90% was noted in the proximal lad.The patient was admitted to the cath lab with st elevation myocardial infarction equivalent.Two drug eluting stents were implanted in the proximal lad, and three additional drug eluting stents were implanted in the proximal to mid right coronary artery (rca).No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of stenosis and myocardial infarction are listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Manufacturer Narrative
A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
 
Event Description
Subsequent to the final mdr, additional information was provided.The patient was re-hospitalized with elevated right heart pressure with significant volume overload [heart failure].The patient was placed on bilevel positive airway pressure (bipap), and the patient¿s condition improved with oxygenation, and later weaned to room air.Intervention was performed to treat restenosis in the left anterior descending artery and the patient condition resolved on (b)(6) 2020.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10744358
MDR Text Key213467509
Report Number2024168-2020-08947
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227301
UDI-Public08717648227301
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup,Followup
Report Date 04/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/17/2020
Device Model Number1550300-38
Device Catalogue Number1550275-38
Device Lot Number9021141
Was Device Available for Evaluation? No
Date Manufacturer Received04/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age29 YR
Patient Weight61
-
-